{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:37:00Z","timestamp":1778942220770,"version":"3.51.4"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2010,10,28]],"date-time":"2010-10-28T00:00:00Z","timestamp":1288224000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1000971","type":"journal-article","created":{"date-parts":[[2010,10,28]],"date-time":"2010-10-28T20:52:41Z","timestamp":1288299161000},"page":"e1000971","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Endothelial Cell Capture of Heparin-Binding Growth Factors under Flow"],"prefix":"10.1371","volume":"6","author":[{"given":"Bing","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changjiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Forsten-Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Fannon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2010,10,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1023\/A:1020778001267","article-title":"Complexation of VEGF with bevaczumab decreases VEGF clearance in rats.","volume":"19","author":"V Hsei","year":"2002","journal-title":"Pharm Res"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/08977199209023937","article-title":"The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies.","volume":"7","author":"KJ Kim","year":"1992","journal-title":"Growth Factors"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1200\/JCO.2001.19.3.843","article-title":"Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer.","volume":"19","author":"MS Gordon","year":"2001","journal-title":"J Clin Oncol"},{"key":"ref4","article-title":"Principles of Anatomy and Physiology","author":"GJ Tortora","year":"1987"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrd2792","article-title":"The FGF family: biology, pathophysiology and therapy.","volume":"8","author":"A Beenken","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1021\/bi991895z","article-title":"Potentiation and inhibition of bFGF binding by heparin: a model for regulation of cellular response.","volume":"39","author":"M Fannon","year":"2000","journal-title":"Biochemistry"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1023\/B:ABME.0000030231.88326.78","article-title":"A reaction-diffusion model of basic fibroblast growth factor interactions with cell surface receptors.","volume":"32","author":"RJ Filion","year":"2004","journal-title":"Ann Biomed Eng"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jtbi.2004.10.020","article-title":"The kinetics of FGF-2 binding to heparan sulfate proteoglycans and MAP kinase signaling.","volume":"233","author":"K Forsten-Williams","year":"2005","journal-title":"J Theor Biol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"4724","DOI":"10.1021\/bi0352320","article-title":"Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly.","volume":"43","author":"OA Ibrahimi","year":"2004","journal-title":"Biochemistry"},{"key":"ref10","first-page":"H2014","article-title":"Computational simulations of local vascular heparin deposition and distribution.","volume":"271","author":"MA Lovich","year":"1996","journal-title":"Am J Physiol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"8876","DOI":"10.1021\/bi00152a026","article-title":"Kinetics of basic fibroblast growth factor binding to its receptor and heparan sulfate proteoglycan: a mechanism for cooperactivity.","volume":"31","author":"MA Nugent","year":"1992","journal-title":"Biochemistry"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1006\/jtbi.2000.2064","article-title":"Potential mechanisms for the regulation of growth factor binding by heparin.","volume":"205","author":"KE Forsten","year":"2000","journal-title":"J Theor Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1007\/s10439-008-9575-z","article-title":"Control of growth factor networks by heparan sulfate proteoglycans.","volume":"36","author":"K Forsten-Williams","year":"2008","journal-title":"Ann Biomed Eng"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1007\/s11538-008-9342-1","article-title":"A mass action model of a Fibroblast Growth Factor signaling pathway and its simplification.","volume":"70","author":"EA Gaffney","year":"2008","journal-title":"Bull Math Biol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"H263","DOI":"10.1152\/ajpheart.00205.2004","article-title":"Intracoronary administration of FGF-2: a computational model of myocardial deposition and retention.","volume":"288","author":"RJ Filion","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1109\/TBME.2008.2002109","article-title":"A computational model of FGF-2 binding and HSPG regulation under flow.","volume":"56","author":"W Shen","year":"2009","journal-title":"IEEE Trans Biomed Eng"},{"key":"ref17","first-page":"435","author":"CJ Zhang"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1006\/excr.1999.4502","article-title":"Phenotype dictates the growth response of vascular smooth muscle cells to pulse pressure in vitro.","volume":"250","author":"C Cappadona","year":"1999","journal-title":"Exp Cell Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/jcb.10226","article-title":"Chronic pulsatile shear stress impacts synthesis of proteoglycans by endothelial cells: effect on platelet aggregation and coagulation.","volume":"86","author":"S Elhadj","year":"2002","journal-title":"J Cell Biochem"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1006\/abio.1997.2494","article-title":"Quantitation of proteoglycans as glycosaminoglycans in biological fluids using an alcian blue dot blot analysis.","volume":"256","author":"S Bjornsson","year":"1998","journal-title":"Anal Biochem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1096\/fj.02-0935fje","article-title":"Binding inhibition of angiogenic factors by heparan sulfate proteoglycans in aqueous humor: potential mechanism for maintenance of an avascular environment.","volume":"17","author":"M Fannon","year":"2003","journal-title":"Faseb J"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/BF00382049","article-title":"Laminar flow in the entrance region of a pipe.","volume":"13","author":"RW Hornbeck","year":"1964","journal-title":"Applied Science Research"},{"key":"ref23","article-title":"Fundamentals of Momentum, Heat, and Mass Transfer","author":"JR Welty","year":"2002"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"17949","DOI":"10.1074\/jbc.271.30.17949","article-title":"Basic fibroblast growth factor binds its receptors, is internalized, and stimulates DNA synthesis in Balb\/c3T3 cells in the absence of heparan sulfate.","volume":"271","author":"M Fannon","year":"1996","journal-title":"J Biol Chem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/(SICI)1097-4652(199708)172:2<209::AID-JCP8>3.0.CO;2-S","article-title":"Endothelial proteoglycans inhibit bFGF binding and mitogenesis.","volume":"172","author":"KE Forsten","year":"1997","journal-title":"J Cell Physiol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"25803","DOI":"10.1016\/S0021-9258(18)35681-3","article-title":"Basic fibroblast growth factor (bFGF) dissociates rapidly from heparan sulfates but slowly from receptors. Implications for mechanisms of bFGF release from pericellular matrix.","volume":"267","author":"D Moscatelli","year":"1992","journal-title":"J Biol Chem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1126\/science.1646484","article-title":"Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation.","volume":"252","author":"AC Rapraeger","year":"1991","journal-title":"Science"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0092-8674(91)90512-W","article-title":"Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor.","volume":"64","author":"A Yayon","year":"1991","journal-title":"Cell"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1126\/science.2432664","article-title":"Angiogenic factors.","volume":"235","author":"J Folkman","year":"1987","journal-title":"Science"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/jcp.1041310118","article-title":"High and low affinity binding sites for basic fibroblast growth factor on cultured cells: absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells.","volume":"131","author":"D Moscatelli","year":"1987","journal-title":"J Cell Physiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/0014-4886(88)90087-8","article-title":"Interactions between basic fibroblast growth factor (FGF) and glycosoaminoglycans in promoting neurite outgrowth.","volume":"102","author":"PA Walicke","year":"1988","journal-title":"Exp Neurol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"9765","DOI":"10.1074\/jbc.M310877200","article-title":"Chondroitin sulfate\/dermatan sulfate hybrid chains from embryonic pig brain, which contain a higher proportion of L-iduronic acid than those from adult pig brain, exhibit neuritogenic and growth factor binding activities.","volume":"279","author":"X Bao","year":"2004","journal-title":"J Biol Chem"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.matbio.2006.10.012","article-title":"Heparan and chondroitin sulfate on growth plate perlecan mediate binding and delivery of FGF-2 to FGF receptors.","volume":"26","author":"SM Smith","year":"2007","journal-title":"Matrix Biol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1074\/jbc.M410412200","article-title":"Structural and sequence motifs in dermatan sulfate for promoting fibroblast growth factor-2 (FGF-2) and FGF-7 activity.","volume":"280","author":"KR Taylor","year":"2005","journal-title":"J Biol Chem"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1593\/neo.08106","article-title":"Prostate cancer cell-derived urokinase-type plasminogen activator contributes to intraosseous tumor growth and bone turnover.","volume":"10","author":"Z Dong","year":"2008","journal-title":"Neoplasia"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jbiotec.2006.02.019","article-title":"A novel flow based hollow-fiber blood-brain barrier in vitro model with immortalised cell line PBMEC\/C1-2.","volume":"125","author":"W Neuhaus","year":"2006","journal-title":"J Biotechnol"},{"key":"ref37","first-page":"481","article-title":"A dynamic model of the blood-brain barrier \u201cin vitro\u201d.","volume":"17","author":"KA Stanness","year":"1996","journal-title":"Neurotoxicology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1083\/jcb.105.1.291","article-title":"Hemodynamics and the vascular endothelial cytoskeleton.","volume":"105","author":"IM Herman","year":"1987","journal-title":"J Cell Biol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1159\/000159253","article-title":"Flow-mediated regulation of endothelin receptors in cocultured vascular smooth muscle cells: an endothelium-dependent effect.","volume":"34","author":"EM Redmond","year":"1997","journal-title":"J Vasc Res"},{"key":"ref40","article-title":"Scaling, why is animal size so important?","author":"K Schmidt-Nielson","year":"1984"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1126\/science.284.5420.1677","article-title":"The fourth dimension of life: fractal geometry and allometric scaling of organisms.","volume":"284","author":"GB West","year":"1999","journal-title":"Science"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1172\/JCI119377","article-title":"Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated?","volume":"99","author":"RD Rosenberg","year":"1997","journal-title":"J Clin Invest"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1357-2725(99)00116-8","article-title":"Heparan sulfate proteoglycans on the cell surface: versatile coordinators of cellular functions.","volume":"32","author":"S Tumova","year":"2000","journal-title":"Int J Biochem Cell Biol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1073\/pnas.91.4.1524","article-title":"Heparinase inhibits neovascularization.","volume":"91","author":"R Sasisekharan","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1126\/science.8456318","article-title":"An essential heparin-binding domain in the fibroblast growth factor receptor kinase.","volume":"259","author":"M Kan","year":"1993","journal-title":"Science"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S1097-2765(00)00073-3","article-title":"Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization.","volume":"6","author":"J Schlessinger","year":"2000","journal-title":"Mol Cell"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1021\/bi992243d","article-title":"Mechanisms of fibroblast growth factor 2 intracellular processing: a kinetic analysis of the role of heparan sulfate proteoglycans.","volume":"39","author":"GV Sperinde","year":"2000","journal-title":"Biochemistry"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bpc.2007.03.010","article-title":"Dimerization of VEGF receptors and implications for signal transduction: a computational study.","volume":"128","author":"F Mac Gabhann","year":"2007","journal-title":"Biophys Chem"}],"container-title":["PLoS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1000971","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T20:48:53Z","timestamp":1636750133000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1000971"}},"subtitle":[],"editor":[{"given":"Paul A.","family":"Cahill","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2010,10,28]]},"references-count":48,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2010,10,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1000971","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,28]]}}}